International
Prosecution Accuses J&J of Avoiding Responsibility for Allegedly Fueling Opioid Crisis
Even after illegally promoting opioid painkillers to reap billions of dollars in profit over the past two decades, Johnson & Johnson has accepted "zero responsibility'' for its central role in ...
Roundup Jury Award Slashed to $25.3M; Bayer Appeal Still Planned
A federal judge on Monday slashed a damages award Bayer AG owed a California man who blamed Roundup weed killer for his cancer, to $25.27 million from $80.27 million, while rejecting the company's ...
Executives On The Move at Allianz Global Corporate & Specialty and AIG
Allianz Global Corporate & Specialty SE appointed three executives to divisions covering areas including alternative risk transfer and global political violence. A former Accenture executive ...
‘The Future at Lloyd’s’ Revamp Effort Elicits Sizable Stakeholder Feedback
When the 10-week consultation period for "The Future at Lloyd's" project ended last week, Lloyd's confirmed that participation was widespread, with more than 4,000 suggestions and comments received ...
U.S. Reportedly Investigating Whether J&J Lied About Talcum Powder Cancer Risks
The U.S. Justice Department is pursuing a criminal investigation into whether Johnson & Johnson lied to the public about the possible cancer risks of its talcum powder, people with knowledge of ...
Going to Monte Carlo for the Rendezvous? What’s It Like?
Have you been to the Reinsurance Rendezvous in Monte Carlo? What would you tell someone thinking of going for the first time about the experience? Carrier Management is looking to compile stories and ...
Executives On The Move at Brit Global Specialty USA and AXA
Veterans of Swiss Re and Redstone Underwriters joined Brit Global Specialty USA in executive roles. A former Goldman Sachs executive signed on with AXA as its new group chief risk officer. *** Brit ...
M&A Drives Still-Growing Demand for Transitional Risk Insurance: Marsh
Use of transactional risk insurance significantly increased in 2018. Policy limits in excess of $1 billion are now available for single transactions as private equity firms and strategic investors ...